Select committee: Health and Social Care Committee

Prevention in health and social care

Closed Opened 18 Jan 2023 Closed 30 May 2024 14 recommendations 11 conclusions
Inquiry scope (the committee's words)
The Health and Social Care Committee has announced ten themes to be examined in its major new inquiry into preventing ill-health. The subjects, ranging from early years and childhood to alcohol and gambling, were chosen after MPs received more than 600 submissions from researchers and organisations involved in preventative healthcare. The inquiry will examine social and environmental factors, for example what living in a healthy place should look like, from housing and indoor air pollution to the number of fast food shops. Access to sexual and reproductive health services, how to promote good mental health, sleep and addressing poor diet are among other areas to be considered. Health and Social Care Committee Chair said: “Whether it’s the air you breathe or the food you put on your plate, there’s an impact on your health. While we can take action as individuals to stay well, the environment we live in has an enormous impact so what should a healthy place look like? “This inquiry will be looking at a wide range of factors and asking what steps can be taken to prevent people slipping into ill-health. “With health and social care services under extreme pressure, this is a crucial moment to identify what can be done to improve health outcomes for people in the longer term. I would argue the future sustainability of the NHS rests on us getting that right.” The full list of topics that the Committee will be considering in the inquiry: healthy places; vaccination; health inequalities; mental health and wellbeing; healthy eating and obesity; smoking, drugs, alcohol, and gambling; sexual health; early years and childhood; cancer prevention; other major conditions. Learn more about the submissions received in the first phase of the inquiry.

Where it stands

The inquiry is closed, opened 18 January 2023.

The committee has published 2 reports, most recently First Report - Prevention in health and social care: healthy places on 19 January 2024.

The government's response to each report

First Report - Prevention in health and social care: healthy places

Published 9 May 2024. The deadline was 19 March 2024.

Summary written by Accountability Index from the government's response. It is not the government's own words.

The government says it accepts some of the Committee's recommendations on healthy places but declines others, and states that it has carefully considered all of them.

  • On the Decent Homes Standard, it accepts the recommendation, saying the Renters (Reform) Bill will bring the private rented sector under a standard for the first time and that it "intend[s] to publish our consultation on an updated DHS soon".
  • On Awaab's Law, it accepts the recommendation. It will publish a consultation response and bring forward secondary legislation for social housing "as soon as practicable", but says the private rented sector needs "a different approach".
  • It declines to consult on design and space standards, stating: "we do not believe it is necessary to consult on our design or space standards at this time."
  • It declines to make OHID a statutory consultee, saying new statutory consultees would need to be "clearly justified", and that it is "not currently looking to extend the list of statutory consultees".

Read the government's response ↗ Report an error

Tenth Report - Prevention in health and social care: vaccination

Published 20 October 2023. The deadline was 27 September 2023.

Summary written by Accountability Index from the government's response. It is not the government's own words.

The Government responds to each of the Committee's five recommendations, setting out ongoing work and consultations, and states it is committed to improving vaccination uptake and regaining the UK's position as a global leader in clinical trials.

  • On widening the vaccination workforce, the Government says it is "reviewing" the use of unregistered professionals, and a consultation launched on 7 August 2023 (closed 18 September 2023) includes an option for a time limited amendment, covering until April 2026, to regulation 247A.
  • On NHS England's vaccination and immunisation delivery strategy, it says "latest thinking" focuses on empowering system leaders to plan local services, and that "the strategy will be published later in 2023".
  • On the O'Shaughnessy review of commercial clinical trials, it has welcomed all recommendations "in principle" and "will consider" delivery of all of them, with "an implementation update" to be provided "in the autumn".
  • On the JCVI and MHRA, it describes the UK system for reviewing new immunisation products as "effective and responsive" and notes £10 million over two years announced for the MHRA at Spring Budget.

Read the government's response ↗ Report an error

Recommendations and conclusions

All 25 recommendations and conclusions

Reports

All reports

Evidence

  • 9 oral evidence sessionsLatest 20 May 2024
  • 586 written submissions
  • 34 witnesses
All evidence

Recent activity

Recommendations and conclusions 25 shown

2: Address practical challenges of time and location preventing vaccination access.

Conclusion · Tenth Report - Prevention in health and social care: vaccination · Addressed to Department of Health and Social Care

Concluded (the committee's words)
Vaccination is the one of the greatest success stories when it comes to preventing infection. Its impact is transformative. This makes it all the more concerning that England did not reach the 95% target for any routine childhood immunisations in 2021/22. The Government and NHS England should constantly strive to maximise the fantastic asset that vaccination represents and to ensure that nobody is excluded from the benefits that it can bring. It is unacceptable that there are people who are unable to take advantage of the important protection that vaccination offers due to practical challenges of time and location that can and must be addressed.

Link to this item · Read this item

3: Covid-19 vaccine rollout success demonstrates benefits of mission-based approach for immunisation.

Conclusion · Tenth Report - Prevention in health and social care: vaccination · Addressed to Department of Health and Social Care

Concluded (the committee's words)
The incredible success of the Covid-19 vaccine rollout showed what can be achieved with a mission-based attitude from Government, which involved making it as easy as possible for everybody to receive the vaccine. Fundamental to that success was the wide range of people that were mobilised to deliver the vaccination, and this is a lesson that cannot be forgotten when considering routine immunisation programmes.

Link to this item · Read this item

4: Consult on amending regulations to give students and retired staff roles in immunisation.

Recommendation · Tenth Report - Prevention in health and social care: vaccination · Addressed to Department of Health and Social Care

Recommended (the committee's words)
To ensure that nobody misses out on vital vaccine protection because of practical challenges such as convenient times or locations, a more flexible delivery model, that makes the most of the wide range of healthcare professionals, is needed. We recommend that the Government carries out a consultation on whether to amend the Human Medicines Regulations 2012 to give medical and nursing students, and recently retired staff, a greater role in routine immunisation delivery.

Link to this item · Read this item

5: Empower local ICS leaders to take ownership of improving vaccination uptake.

Conclusion · Tenth Report - Prevention in health and social care: vaccination · Addressed to Department of Health and Social Care

Concluded (the committee's words)
We agree that there is a need for national oversight of vaccination programmes and the value of this was clear during the Covid-19 pandemic. However, with routine immunisation programmes, the role of the Government and, in particular, NHS England must be limited to the more strategic, national level. Local ICS leaders, public health directors and health and care professionals have the best knowledge of the factors driving lower uptakes and the interventions needed to try and tackle that. As such, ICS leadership must step-up and take ownership of improving uptake in their area, and be supported to do so.

Link to this item · Read this item

6: Provide Government commitment and support to NHS England's vaccination and immunisation strategy.

Recommendation · Tenth Report - Prevention in health and social care: vaccination · Addressed to Department of Health and Social Care

Recommended (the committee's words)
We welcome NHS England’s intention to set out an integrated vaccination and immunisation strategy. This strategy will be vital if England is to meet the 95% target for all childhood vaccinations and to address the variations in uptake across routine immunisation programmes. The strategy must receive the commitment and support from the Government that it will need to succeed.

Link to this item · Read this item

7: Require NHS England's strategy to address access, professional roles, local empowerment, and communication.

Recommendation · Tenth Report - Prevention in health and social care: vaccination · Addressed to Department of Health and Social Care

Recommended (the committee's words)
The NHS England integrated vaccination and immunisation strategy must: a) have a strong focus on the action that is needed to tackle the practical challenges that limit access to vaccination; b) set out how to make best use of the wide range of healthcare professionals able to administer vaccinations; c) empower local leaders to pursue ways of addressing uptake in their own areas; and d) set out guidance and examples of best practice around how voices other than NHS England can be used to communicate important messaging about vaccination programmes.

Link to this item · Read this item

8: Decline in UK clinical trial activity threatens global leadership position.

Conclusion · Tenth Report - Prevention in health and social care: vaccination · Addressed to Department of Health and Social Care

Concluded (the committee's words)
We are deeply concerned to hear about the decline in clinical trial activity and the risk to the UK’s position as a global leader in this area. The challenges highlighted by witnesses, particularly around the administrative aspects of running a trial, are clearly fixable and it is vital that they are addressed if the UK is to make the most of its world-leading academic and research expertise.

Link to this item · Read this item

9: Swiftly implement O’Shaughnessy review recommendations for clinical trials and patient engagement.

Recommendation · Tenth Report - Prevention in health and social care: vaccination · Addressed to Department of Health and Social Care

Recommended (the committee's words)
We welcome Lord O’Shaughnessy’s review of commercial clinical trials, which chimed with a lot of the evidence that we heard in this part of our inquiry. The Government’s positive response to the recommendations is encouraging. We especially endorse the following recommendations and will be keeping a watching brief on the Government’s progress in implementing them, which we expect to be swift: a) Recommendations 2, 3 and 4 to address overly slow and bureaucratic clinical trial set-up and approval processes, in particular the goal for a 60-day turnaround for approvals b) Recommendations 14 - 17 to address the absence of conversation about research from interactions between clinicians and patients and increase the profile and awareness of research among disadvantaged or marginalised groups c) Recommendation 27 to develop an action plan outlining how the Government and delivery partners will implement the recommendations of the review.

Link to this item · Read this item

10: Prepare regulatory and delivery systems for future personalised preventative healthcare innovations.

Recommendation · Tenth Report - Prevention in health and social care: vaccination · Addressed to Department of Health and Social Care

Recommended (the committee's words)
Exciting innovations are on the horizon and have the potential to transform preventative healthcare. While the timeframe for such innovations, like a personalised cancer vaccine, is unknown, future planning must be done on the assumption that personalised therapeutics will become available. NHS England, and the MHRA and JCVI, need to be ready to play their part in ensuring these innovations can reach patients as quickly as possible, and the Department itself has a crucial role in ensuring this happens. It would be incredibly disappointing to reach a point where the vaccines themselves were ready but the infrastructure to approve and deliver them was still some time away.

Link to this item · Read this item

11: Require DHSC and NHS England to submit plan for regulatory readiness and resourcing.

Recommendation · Tenth Report - Prevention in health and social care: vaccination · Addressed to Department of Health and Social Care

Recommended (the committee's words)
The Department of Health and Social Care and NHS England must lay before Parliament a plan for how they intend to ensure all relevant regulatory and delivery systems are ready to assess and deliver these new innovations to patients. As part of that plan, the JCVI and the MHRA must be adequately resourced and supported, focusing on modelling capability at the JCVI and, at the MHRA, on recruiting and retaining expertise relevant to new innovations, especially in personalised health.

Link to this item · Read this item

1: Place of residence significantly impacts health, driving preventable health inequalities in disadvantaged areas.

Conclusion · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Concluded (the committee's words)
The places where people live—homes, communities and neighbourhoods—affect their health and wellbeing substantially. Place, health inequalities and the likelihood of developing preventable health conditions are inextricably linked. People from less well-off groups, and those who live in less well-off neighbourhoods, have a much higher likelihood of developing life-limiting health conditions and associated comorbidities, and of dying prematurely from the effects of those conditions. Although much of this ill-health is preventable, it is also often not within the power of individuals to control.

Link to this item · Read this item

2: Lack of progress developing "healthy places" despite strong evidence, impacting NHS sustainability.

Conclusion · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Concluded (the committee's words)
The evidence base on the importance of place in protecting good health is stronger than it has ever been. But as we discuss in the next chapter, we have known about the relationship between health and place for decades, if not longer. It is frustrating that more progress has not been made already. A determined focus on developing “healthy places” that can prevent ill-health amongst those most at risk is now vital in easing pressures on the NHS, and building a sustainable service for generations to come.

Link to this item · Read this item

3: Poor quality private rented housing burdens NHS, lacking promised minimum quality standard.

Conclusion · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Concluded (the committee's words)
Homes in the private rented sector contribute disproportionately to both the total number of poor quality homes and the costs that poor housing causes to the NHS. The existence of a statutory minimum standard for housing in the social rented sector is not enough on its own to protect tenants and the health service from the many preventable health impacts of poor quality and unsafe housing. The Renters (Reform) Bill contains some welcome steps to further protect tenants. But recent high profile cases involving tenants in social housing have demonstrated that the health impact of poor quality housing can be catastrophic. Over three years after the Government first committed to review and then extend the Decent Homes Standard to the private rented sector, no legal minimum quality standard exists to protect tenants in private rentals.

Link to this item · Read this item

4: Require Government to update and implement Decent Homes Standard for all rented sectors promptly.

Recommendation · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Recommended (the committee's words)
We recommend the Government proceeds without delay in the consultation necessary to update the Decent Homes Standard for the social rented sector and in implementing a Decent Homes Standard for the private rented sector. It should set out a timetable for doing so in response to this report.

Link to this item · Read this item

5: Expedite Awaab's Law implementation and extend safeguards against health hazards to private tenants.

Recommendation · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Recommended (the committee's words)
It is welcome that the Government’s has proposed measures to protect social sector tenants from the worst impacts of unhealthy homes, via the implementation of “Awaab’s law”. We recommend that the Government act quickly on the outcome of its consultation on this topic for social sector tenants. It should also consider how similar safeguards could be extended to tenants in the private rented sector who are affected by housing hazards, such as damp and mould, that can pose an immediate danger to health.

Link to this item · Read this item

6: Voluntary quality standards for housing development fail to adequately protect residents' health.

Recommendation · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Recommended (the committee's words)
An absence of hazards is not enough on its own to ensure that housing protects residents’ health. Space, design and location matter, and these should not be the preserve of those who are able to afford more expensive housing. Several standards exist to support the development of housing that is more widely protective of good health. Dwellings created under Permitted Development Rights (PDR), which comprise some of the most egregious examples of housing that is bad for health that we have seen during this inquiry, are now subject to minimum safeguards on space and light. These are welcome and much-needed but they are also an exception: adherence to any kind of quality standard is voluntary for the vast majority of developments and dwellings. Building enough homes is important, but the Government must require developers to aim higher, with quality housing and development that protects residents’ health.

Link to this item · Read this item

7: Consult on making health-related design and space standards mandatory for all new dwellings.

Recommendation · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Recommended (the committee's words)
We recommend the Government consult on both the content of existing design and space standards as they relate to health, and on the implications of making such standards mandatory for new dwellings—both for developments requiring standard planning consent, and for both householder and change of use PDR developments.

Link to this item · Read this item

8: National Planning Policy Framework fails to sufficiently prioritise health promotion in local planning.

Conclusion · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Concluded (the committee's words)
Local authorities and councils necessarily consider a wide range of criteria in assessing planning applications. This, alongside pressures on their resources and skills, makes it difficult for them to prioritise ensuring that planning promotes health. The lack of changes to requirements relating to health in the revised National Planning Policy Framework is a disappointing missed opportunity to make promotion of health a higher priority for planning authorities.

Link to this item · Read this item

9: Lack of clarity and integration post-PHE hinders health promotion in planning applications.

Recommendation · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Recommended (the committee's words)
The former Public Health England’s Healthy Places team had a clear remit to support healthy development. Following PHE’s dissolution and the division of its responsibilities, there is a lack of clarity over which part of DHSC is now responsible for this role, and a lack of formal integration between DHSC and the organisations responsible for assessing planning applications. These is, however, encouraging evidence elsewhere of Departments enabling a greater focus on health in planning: for example, Active Travel England’s statutory role assessing applications for large housing developments. There are clear opportunities to go further in this vein: for example, by clarifying and formalising OHID’s role.

Link to this item · Read this item

10: Make OHID a statutory consultee for all new large housing developments.

Recommendation · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Recommended (the committee's words)
We recommend that OHID be made a statutory consultee for new large housing developments, building on role already accorded to Active Travel England in supporting inclusive, effective and health-protecting development.

Link to this item · Read this item

11: GPs lack confidence in social prescribing, leading to underutilisation for underserved groups.

Conclusion · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Concluded (the committee's words)
Frontline health and social care staff do not only deal with immediate medical needs. People also present to the health service with issues that relate to unmet social needs, which can in turn, over time, develop into medical needs. Increased use of social prescribing can both relieve pressure on clinical pathways and protect good health through enhancing people’s connections with, and ability to participate in activities in their local communities—particularly for people who often lack resources to access these activities independently. There is potential for health services to make much greater use of this approach amongst groups that are currently underserved by social prescribing, such as young people. Many GPs, however, do not feel as confident working with social prescription pathways as they do with the clinical Prevention in health and social care: healthy places 27 pathways that their training focuses on. Building confidence amongst frontline providers in recommending social provision will be key to both protecting and improving individuals’ health, and promoting more cohesive, health-enhancing communities.

Link to this item · Read this item

12: Establish national social prescribing strategy to improve practitioner confidence and youth engagement.

Recommendation · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Recommended (the committee's words)
We recommend DHSC work with NHS England and existing networks and providers to develop a national strategy for social prescribing. This should aim to improve understanding amongst frontline clinical practitioners of the benefits of social prescribing and to improve their confidence in offering social and community-based solutions to unmet social needs, and to increase use of social prescriptions for young people across all referral routes, including hospitals, schools and other educational and community settings. It should include resources, guidance and case studies, and should focus in particular on groups that are currently underserved, where the greatest long-term preventative impacts may be accrued.

Link to this item · Read this item

13: Short-term health pressures undermine long-term prevention strategies for creating healthy places.

Conclusion · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Concluded (the committee's words)
Integrated Care Systems aim to enable a stronger focus on prevention, and on the specific approaches needed in different communities to help ensure that they are “healthy places”. But this is a long-term agenda. The mixed longer-term outcomes of initiatives such as Healthy New Towns demonstrate that building communities that protect good health is not something that can be accomplished through isolated programmes over a few years. The immediate pressures on health services are numerous and compelling, and there is already evidence that these are crowding out longer-term strategies including prevention. Because the numerous costs of “unhealthy places” fall so heavily on the health service, it is essential that the right systems, people and funding are in place for the long term to maintain a focus on prevention and protecting population health.

Link to this item · Read this item

14: Reconsider mandating public health representatives on Integrated Care Boards to prioritise prevention

Recommendation · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Recommended (the committee's words)
We have previously recommended that all ICBs should include a public health representative, such as a public health director, and that DHSC considers making this a mandatory requirement. In response, the Department said it agreed that prevention needs to be a priority, but emphasised the importance of protecting ICS autonomy. The evidence that we have heard in this inquiry reaffirms our view that having the right people in place is crucial to ensuring the prevention agenda is not crowded out. Given what we have heard about impact that these individuals can have in ensuring a longer-term focus, we recommend that DHSC reconsiders the case for mandating representatives in this role.

Link to this item · Read this item

15: Healthy places are vital for population health, requiring long-term whole-Government commitment and coordination

Conclusion · First Report - Prevention in health and social care: healthy places · Addressed to Department of Health and Social Care

Concluded (the committee's words)
Healthy places are vital to protecting people’s physical and mental health from both direct and indirect consequences and in turn, to building a sustainable health service. “Healthy places” include both the built environment—homes, communities and neighbourhoods—and wider environmental factors, such as air quality and emission levels. The benefits of building healthier places go far beyond DHSC and the health service, and achieving these benefits requires buy-in from a range of Government Departments. In turn, the benefits of healthy places are crucial to a range of wider priorities, including building a stronger, more productive economy and protecting the environment in which we live. The problems caused by “unhealthy places” are 28 Prevention in health and social care: healthy places whole-society problems. Tackling them will require long-term thinking and whole- Government solutions, including commitment, leadership and co-ordination from the very top.

Link to this item · Read this item

Reports

2 reports

Oral evidence sessions

9 sessions

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.

Date Session and witnesses Source
20 May 2024
Oral evidence session
Adrian Chiles, TV presenter and author of The Good Drinker, Ailsa Rutter OBE · Fresh and Balance, Alice Wiseman · Association of Directors of Public Health, Sir Ian Gilmore · Alcohol Health Alliance
View ↗
6 Feb 2024
Formal meeting (oral evidence session) - 09:30 - 11:30 Tues 6 Feb 2024
Andy Tighe · The British Beer and Pub Association, Asma Khalil · The Royal College of Obstetricians and Gynaecologists (RCOG), Hazel Cheeseman · Action Against Smoking, Karen Tyrell · Drinkaware, Matt Lambert · The Portman Group, Professor Peter Hajek · Wolfson Institute of Population Health Barts and The London School of Medicine and Dentistry Queen Mary University of London, Sandra Ionno Butcher · The National Organisation for FASD
View ↗
5 Feb 2024
Formal Meeting (oral evidence session)
Professor Javed Khan OBE · Equi
View ↗
18 Oct 2023
Oral evidence session
Chris Naylor · The King's Fund, Dr Mark Green · University of Liverpool, Julia Thrift · Town and Country Planning Association, Simon Reeve · Office for Health Improvement and Disparities
View ↗
5 Sep 2023
Oral evidence session
David Finch · The Health Foundation, Dr Henry Burridge · Imperial College London, Dr Jill Stewart · University of Greenwich, Helen Garrett · Building Research Establishment
View ↗
11 Jul 2023
Oral evidence session
Chris Boardman · Active Travel England, Mark Lawrie · StreetGames, Tom Hollingsworth · Sport England
View ↗
23 May 2023
Oral evidence session
Dr Nikki Kanani · NHS England, Maria Caulfield · Department of Health and Social Care
View ↗
18 Apr 2023
Oral evidence session
Ben Lucas · The Association of the British Pharmaceutical Industry (ABPI), Doctor Mary Ramsay · UK Health Security Agency, Professor Dame Jenny Harries · UK Health Security Agency, Professor Sir Andrew Pollard · Joint Committee on Vaccination and Immunisation, Rebecca Catterick · Sanofi Vaccines UK & Ireland, Stuart Carroll · Moderna
View ↗
21 Feb 2023
Oral evidence session
Dr Jeanelle De Gruchy, Deputy Chief Medical Officer for England · Department for Health and Social Care, Jonathan Marron · Department for Health and Social Care, Professor Sir Chris Whitty, Chief Medical Officer for England
View ↗

Written evidence

586 submissions recorded

Submission metadata is shown here; use the source links to read the evidence on Parliament’s website.

Showing the latest 50 of 586 recorded submissions. Written evidence in the activity timeline uses this same preview. Browse the inquiry on Parliament.

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.

ReferenceDateSubmitter
PHS0626 24 Apr 2024 Drinkaware
PHS0625 19 Apr 2024 Action on Smoking and Health
PHS0624 19 Apr 2024 Portman Group
PHS0623 20 Mar 2024 Commercial Determinants Research Group at the London School of Hygiene & Tropical Medicine, and the University of Edinburgh
PHS0622 5 Mar 2024 The National Organisation for FASD
PHS0621 5 Dec 2023 All Party Parliamentary Group for Healthy Homes and Building
PHS0620 29 Nov 2023 National Housing Federation
PHS0619 14 Nov 2023 Dr Mark Green, University of Liverpool
PHS0617 14 Nov 2023 Richmond Group of Charities
PHS0616 14 Nov 2023 NHS Providers
PHS0615 6 Sep 2023 LEAPP Alliance
PHS0614 6 Sep 2023 Sport England
PHS0613 6 Sep 2023 Town and Country Planning Association (TCPA)
PHS0612 7 Jun 2023 Moderna Biotech UK Limited
PHS0611 23 May 2023 Association of the British Pharmaceutical Industry (ABPI)
PHS0025
Full text not held
23 May 2023 Anonymous
PHS0159 23 May 2023 Royal College of Obstetricians and Gynaecologists
PHS0126 26 Apr 2023 Marion Brown
PHS0187 26 Apr 2023 Colin Slasberg
PHS0280 26 Apr 2023 Mrs Tracy Leach, Wakefield Council
PHS0438
Full text not held
26 Apr 2023 Anonymous
PHS0566 26 Apr 2023 Professor Gerome Breen, King's College London
PHS0579 26 Apr 2023 Dr Ingrid Wilkinson Hart, Wiltshire Health and Care
PHS0587 26 Apr 2023 NIHR Older People and Frailty Policy Research Unit
PHS0606 28 Mar 2023 National AIDS Trust
PHS0177 22 Mar 2023 Dr Rhiannon Thompson, Imperial College London
PHS0176 22 Mar 2023 FEAST
PHS0175 22 Mar 2023 MSD
PHS0174 22 Mar 2023 Cereal Partners Worldwide
PHS0173 22 Mar 2023 Sunderland Smokefree Partnership
PHS0172 22 Mar 2023 BAPIO British Association of Physicians of Indian Origin
PHS0171 22 Mar 2023 Football Foundation
PHS0170 22 Mar 2023 Royal College of Psychiatrists
PHS0169 22 Mar 2023 Intergenerational Foundation
PHS0168 22 Mar 2023 PharmaPlus Ltd
PHS0167 22 Mar 2023 Professor John Wright, Bradford Institute for Health Research
PHS0166 22 Mar 2023 Care Visions
PHS0165 22 Mar 2023 Alcohol Change UK
PHS0164 22 Mar 2023 Culture, Health & Wellbeing Alliance CIC
PHS0162 22 Mar 2023 Sarah Champion, House of Commons
PHS0161 22 Mar 2023 Healthworks Ventures Ltd
PHS0160 22 Mar 2023 The Challenging Behaviour Foundation
PHS0158 22 Mar 2023 Just Fair
PHS0157 22 Mar 2023 Food and Drink Federation
PHS0156 22 Mar 2023 Dr Jo Wilding, University of Sussex
PHS0155 22 Mar 2023 AstraZeneca UK
PHS0154 22 Mar 2023 World Cancer Research Fund
PHS0153 22 Mar 2023 Health Inequalities Policy Reseach Group, University of Liverpool
PHS0152 22 Mar 2023 In Kind Direct
PHS0151 22 Mar 2023 Dr Juliet Wakefield , Nottingham Trent University

Who gave evidence

34 witnesses

On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.

WitnessOrganisationSessions
Adrian Chiles, TV presenter and author of The Good Drinker Not recorded 1
Ailsa Rutter OBE · Director Fresh and Balance 1
Alice Wiseman · Vice President Association of Directors of Public Health 1
Andy Tighe · Director of Strategy and Policy The British Beer and Pub Association 1
Asma Khalil · Vice President for Academia and Strategy The Royal College of Obstetricians and Gynaecologists (RCOG) 1
Ben Lucas · Board Member The Association of the British Pharmaceutical Industry (ABPI) 1
Chris Boardman · National Active Travel Commissioner Active Travel England 1
Chris Naylor · Senior Fellow in Health Policy The King's Fund 1
David Finch · Associate Director, Healthy Lives Team The Health Foundation 1
Doctor Mary Ramsay · Director of Public Health Programmes UK Health Security Agency 1
Dr Henry Burridge · Senior Lecturer Imperial College London 1
Dr Jeanelle De Gruchy, Deputy Chief Medical Officer for England · Deputy Chief Medical Officer Department for Health and Social Care 1
Dr Jill Stewart · Associate Professor in Public Health University of Greenwich 1
Dr Mark Green · Reader in Health Geography University of Liverpool 1
Dr Nikki Kanani · Director of Clinical Integration and Deputy SRO of NHS Covid-19 Vaccination Programme NHS England 1
Hazel Cheeseman · Deputy Chief Executive Action Against Smoking 1
Helen Garrett · Principal Consultant Building Research Establishment 1
Jonathan Marron · Director General for Primary Care and Prevention Department for Health and Social Care 1
Julia Thrift · Director of Healthier Place-making Town and Country Planning Association 1
Karen Tyrell · Chief Executive Drinkaware 1
Maria Caulfield · Parliamentary Under-Secretary of State Department of Health and Social Care 1
Mark Lawrie · Chief Executive StreetGames 1
Matt Lambert · Chief Executive The Portman Group 1
Professor Dame Jenny Harries · Chief Executive UK Health Security Agency 1
Professor Javed Khan OBE Equi 1
Professor Peter Hajek · Director of Health and Lifestyle Research Unit Wolfson Institute of Population Health Barts and The London School of Medicine and Dentistry Queen Mary University of London 1
Professor Sir Andrew Pollard · Chair Joint Committee on Vaccination and Immunisation 1
Professor Sir Chris Whitty, Chief Medical Officer for England Not recorded 1
Rebecca Catterick · General Manager Sanofi Vaccines UK & Ireland 1
Sandra Ionno Butcher · Chief Executive The National Organisation for FASD 1
Simon Reeve · Deputy Director, Public Health Systems and Workforce Office for Health Improvement and Disparities 1
Sir Ian Gilmore · Chair Alcohol Health Alliance 1
Stuart Carroll · Director of Market Access and Policy Affairs Moderna 1
Tom Hollingsworth · Chief Executive Sport England 1